Pay in 4 interest-free payments of $5.12 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
528,529,530 Tivanisiran (SYL1001), an unmodified siRNA eye drop developed by Sylentis, targets the transient receptor potential vanilloid 1 mRNA to alleviate ocular discomfort and pain
Accueil Fournir toute assistance mdicale, sanitaire, dducation la sant ou de gestion de structures de soins ou denseignement en soins infirmiers en Afrique 2026-08-02T16:08:24+02:00 Solidarit Sant et Dveloppement ASBL Joomla
PubMed PMID: 36707132
This makes it unique among cognitive compounds: it can be taken in forms that reach the brain directly, where it interacts with specific receptor systems that drive the physical growth of neural connections
US$ 24.89
US$ 23.58
US$ 27.05
US$ 26.10
US$ 20.09
US$ 26.75
US$ 20.35
US$ 26.97
US$ 23.50
